Search Login Register
Anaphylaxis
(Anaphylactic Shock)
Summary
Description:
An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
Also Known As:
Anaphylactic Shock; Anaphylactic Reactions; Reaction, Anaphylactic; Reactions, Anaphylactic; Anaphylactic Reaction Show All >>
Networked: 9134
relevant articles (263 outcomes,
557 trials/studies)
for this Disease
Key Drugs and Agents for Anaphylaxis
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Epinephrine (Adrenaline)
:
43 outcomes 46 studies in 629 results
:
FDA 93
Generic
-
Venoms
:
32 outcomes 19 studies in 318 results
: IBA
-
Immunoglobulin E (IgE)
:
29 outcomes 79 studies in 1297 results
: IBA
-
Antigens
:
15 outcomes 40 studies in 610 results
: IBA
-
Histamine (Histamine Dihydrochloride)
:
12 outcomes 39 studies in 600 results
:
FDA 1
-
Histamine Antagonists (Antihistamines)
:
11 outcomes in 83 results
: IBA
-
Adrenal Cortex Hormones (Corticosteroids)
:
8 outcomes 1 study in 68 results
: IBA
-
Immunoglobulin G (IgG)
:
7 outcomes 18 studies in 236 results
: IBA
-
Tryptases (Tryptase)
:
7 outcomes 11 studies in 232 results
: IBA
-
Latex
:
6 outcomes 14 studies in 342 results
: IBA
Show All >>
Diseases Related to Anaphylaxis
-
Hypersensitivity (Allergy)
-
Bites and Stings (Sting)
-
Asthma (Bronchial Asthma)
-
Anaphylaxis (Anaphylactic Shock)
-
Rhinitis
Show All >>
Key Therapies for Anaphylaxis
Efficacy Chart >>
-
Immunotherapy
:
43 outcomes 17 studies in 308 results
-
Injections
:
6 outcomes 1 study in 134 results
-
Intramuscular Injections
:
6 outcomes 1 study in 25 results
-
Resuscitation
:
3 outcomes 1 study in 62 results
-
Anesthesia
:
2 outcomes 7 studies in 123 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.